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Ultrasound scan to detect acalculous
cholecystopathy in immunocompromised
hosts with unexplained fever
We found a significant prevalence of acalculous
cholecystopathy in a group of patients with hema-
tologic malignancies and unexplained fever. Ultra-
sound scan (US) detected a case of acute cholecys-
titis, two of gallbladder overdistension and biliary
sludge, and one of striated gallbladder wall thick-
ening. US proved effective in early identification of
abdominal infection site.
Sir,
In immunocompromised hosts, biliary injury may
be due directly to opportunistic infection or may be
related to endotoxins released during bacterial sep-
sis.1-3
We investigated 55 unselected immunocompro-
mised patients, suffering from hematologic malig-
nancies and fever of unknown origin (FUO), using
abdominal ultrasound (US) scan with the aim of
defining the infection site. The US examination was
carried out at patient’s bedside, within the first 2 days
after the appearance of fever and subsequently, using
portable Hitachi equipment with a 3.5 MHz probe.
US gallbladder examination was used to monitor
changes in diameters, wall thickening, formation of
intraparietal abscess and perforation.
Of the 55 patients studied, four (7%) had a chole-
cystopathy in the absence of calculi and of bile duct
obstruction or dilation: 1 case of acute cholecystitis
complicated by empyema, 2 cases of gallbladder
overdistension and biliary sludge, one of which with
wall thickening, and 1 case of striated gallbladder
wall thickening (Table 1). None of these four patients
had received total parenteral nutrition or had a his-
tory of primary gallbladder disease; two (#1 and 3)
had received antimicrobial prophylaxis because of a
previous course of chemotherapy and had a central
venous line inserted. All patients had high grade fever,
abdominal symptoms which did not require anal-
gesics, mild alteration in liver function tests and neg-
ative microbiological examination. The diagnosis of
cholecystopathy was defined by US scan in all cases.
The main gallbladder findings were positive Murphy’s
sign (all cases), wall thickening which was striated in
two, overdistension, biliary sludge (three cases) and
intraparietal abscess (one case) (Figure 1). Other US
findings were hepatomegaly, splenomegaly and mild
peritoneal and pleural effusions. In patient #1 com-
puted tomography confirmed the US findings (Figure
1). This patient underwent emergency laparotomy
and cholecystectomy: an empyema of gallbladder,
without calculi, was found; Enterococcus fecalis grew
from bile culture. Unfortunately, he died a few days
later of cardiorespiratory failure. The other patients
received conservative medical treatment including
broad-spectrum antibiotics, granulocyte colony-stim-
ulating factor (patients #2 and #3) and bowel rest;
during this treatment US follow-up documented
improvement of the gallbladder abnormalities. 
Our survey confirms that cholecystopathy related
Table 1. Clinical, laboratory and ultrasound findings in immunocompromised patients with FUO and gallbladder abnormality.
Pt. Sex, age Basic Immunologic Abdominal Abnormal liver Gallbladder Other US Treatment Outcome
(years) disease status symptoms tests° US findings findings
1 M, 71 AML  M4 aplastic phase fever, right pain, transaminases, ALP overdistension (diame- hepatomegaly, cholecystectomy died of post-
after induction distension,  and -GT (x3); ters: long. 11 cm; antero- moderate right operative
chemotherapy* vomiting albumin 2.9 g/dL posterior 4.1 cm), striated pleural effusion complications
wall thickening (10 mm),
biliary sludge, positive  
Murphy’s sign,
intraparietal abscess
2 F, 66 RAEB-T neutropenia fever, moderate transaminases (x2); overdistension (diame- hepatomegaly, ceftriaxone 2 g daily, recovery
related to bone right pain, albumin 2.8 g/dL ters: long. 10 cm; antero- mild peritoneal amikacin 1 g daily, 
marrow hypo- distension posterior 4.5 cm), wall  effusion G-CSF 300 µg daily,
function thickening (4 mm), biliary bowel rest
sludge, moderately
positive Murphy’s sign
3 F, 60 ALL  L2 aplastic phase fever, moderate albumin 3 g/dL overdistension (diame- hepatomegaly, meropenem 3 g daily, recovery
after salvage right pain, ters: long. 11 cm; antero- mild peritoneal amikacin 1 g daily, 
chemotherapy** distension posterior 5 cm), biliary and right pleural teicoplanin 200 mg  
sludge, moderately effusion daily, G-CSF 300 µg
positive Murphy’s sign daily, bowel rest
4 M, 72 WM mild fever, moderate transaminases (x2); striated wall thickening hepatomegaly, ceftriaxone 2 g daily, recovery
neutropenia right pain, albumin 2.8 g/dL (10 mm), moderately splenomegaly, bowel rest
distension positive Murphy’s sign mild peritoneal 
effusion
FUO = fever of unknown origin, US= ultrasound scan, AML= acute myeloid leukemia, ALL= acute lymphoblastic leukemia, RAEB-T = refractory anemia with blast
excess in transformation, WM= Waldenström’s macroglobulinemia, ALP= alkaline phosphatase, -GT= glutamyl-transpeptidase, G-CSF = granulocyte colony-stimu-
lating factor. °Fold increase as compared to normal values. *According to the EORTC-GIMEMA AML 13 Protocol. **A schedule containing cytarabine and idaru-
bicin.
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to infectious causes, even in the absence of calculi or
of bile duct abnormality, has a significant prevalence
in a group of patients suffering from hematologic
malignancies complicated by FUO.4,5 In these cases,
as in other settings,6-8 abdominal US scan proved to
be a valuable tool for rapid detection of the infec-
tion site, thus moving a number of patients from
FUO to clinically documented infection and ulti-
mately leading to more appropriate treatment.9 In
our small series, one patient had gallbladder empye-
ma; the others had a clinical syndrome characterized
by high fever, moderate right abdominal pain, serosi-
tis and US findings strongly suspicious of gallbladder
distress.3 In this group of patients, close US follow-
up associated with correct antibiotic therapy, sup-
portive treatment and bowel rest were an effective
method to avoid potentially dangerous surgery.10
We see US examination as the natural continua-
tion and extension of the physician’s manual action,
and a potentiation of his semeiotic sensitivity. It is a
rapid, safe, effective and inexpensive diagnostic tool
for detecting the site of infection in immunocom-
promised patients with FUO, with special attention
to the gallbladder.
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Fludarabine-containing regimen followed by
autologous peripheral blood stem cell
transplantation in unselected patients with
acute myeloid leukemia: a single center
experience
Fludarabine has been recently reported as inef-
fective in mobilizing peripheral blood stem cells
(PBSC) in acute myeloid leukemia (AML) patients.
We report herein on 27 AML patients, 9 of them
being eligible for peripheral blood stem cell trans-
plantation (PBSCT). Eight of the 9 successfully
Figure 1. Abdominal US findings in representative cases of
immunocompromised patients: overdistended gallbladder
with striated wall thickening (A) containing biliary sludge (B)
in patient #1; marked striated thickening of gallbladder wall
in patient #4 (C and D). Gallbladder CT scan of patient #1,
confirming the US findings (E).
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